Showing 671-680 of 3101 results for "".
Clinical Diagnostic Evaluation of Dystonia
https://practicalneurology.com/diseases-diagnoses/movement-disorders/clinical-diagnostic-evaluation-of-dystonia/32167/A thorough patient history and examination are needed to establish the clinical diagnosis of dystonia; subsequent laboratory, imaging, and genetic testing can assist in identification of etiology and a course of treatment.Movement Disorders Moment: Focused Ultrasound in Movement Disorders: A Novel, Minimally Invasive Approach
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-focused-ultrasound-in-movement-disorders-a-novel-minimally-invasive-approach/32019/Focused ultrasound as a recent addition to treatment approaches for common movement disorders, such as essential tremor and Parkinson disease.Understanding Dystonia: A Practical Approach to Diagnosis and Management
https://practicalneurology.com/diseases-diagnoses/movement-disorders/understanding-dystonia-a-practical-approach-to-diagnosis-and-management/49157/Clinical history helps corroborate the diagnosis of dystonia and provides clues to its etiology; however, the diagnosis rests on clinical examination, because no gold standard laboratory or imaging tests are available.- How Sleep Disruption Can Complicate Neurological Diseaseshttps://practicalneurology.com/diseases-diagnoses/sleep/pn0905-sleep-disorders-pdf/31403/The Interplay Between Sleep Disorders and Neurological ConditionsSleep disorders have long been underrecognized in the field of neurology, with many patients and physicians overlooking their prevalence and impact. Recent advancements, however, highlight the critical role of sleep in enhancing qualit
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31325/In the latest issue of Practical Neurology, Editor-in-Chief Jack Persico examines the delicate balance the FDA maintains between protecting public health and respecting individual autonomy. The discussion highlights ongoing debates over the agency’s regulatory actions, questioning whether they serve
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/30970/In the November 2008 issue of *Practical Neurology*, Paul F. Winnington III explores the diminishing role of serendipitous discoveries in modern clinical practice. He reflects on how the term "serendipitous discovery," once a staple in medical discourse, now appears predominantly in historical conte
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31178/Practical Neurology May 2007 Highlights: Updated Ischemic Stroke Guidelines and Emerging Neurological ResearchThe latest issue of *Stroke* features the American Stroke Association's updated guidelines for early management of adult ischemic stroke patients. Key revisions emphasize streamlined acute s
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31497/Natalizumab (Tysabri) in Multiple Sclerosis Management: A Comprehensive OverviewNatalizumab, marketed as Tysabri, represents a significant advancement in the treatment of relapsing-remitting multiple sclerosis (RRMS). As the first α4-integrin antagonist within the selective adhesion molecule (SAM) i
- Building a better UPDRShttps://practicalneurology.com/columns/practice-management/building-a-better-updrs/31010/Since the late 1980s, the Unified Parkinson’s Disease Rating Scale (UPDRS) has been a cornerstone in assessing Parkinson’s Disease (PD), primarily focusing on motor symptoms such as finger tapping, fist opening, and rising from a chair. However, over the past two decades, advancements in PD research
An Update on the Management of Chronic Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-the-management-of-chronic-migraine/30697/In 1672, Thomas Willis provided the first description of chronic migraine (CM) when he reported the case of the philosopher, Anne, Viscountess Conway, who was also treated by William Harvey and Robert Boyle without success.1-4 Has our treatment of chronic migraine since improved?